We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Updated: 12/31/1969
A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Utility of Interface Pressure Mapping
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Utility of Interface Pressure Mapping
Status: Enrolling
Updated: 12/31/1969
Updated: 12/31/1969
Click here to add this to my saved trials
Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults
Updated: 12/31/1969
Safety, Reactogenicity, Tolerability, Immunogenicity and Efficacy of Live Attenuated ETEC ACE527 Vaccine Administered Alone or With a Double Mutant E. Coli Heat Labile Toxin (dmLT) in Healthy Adult Volunteers
Status: Enrolling
Updated: 12/31/1969
Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults
Updated: 12/31/1969
Safety, Reactogenicity, Tolerability, Immunogenicity and Efficacy of Live Attenuated ETEC ACE527 Vaccine Administered Alone or With a Double Mutant E. Coli Heat Labile Toxin (dmLT) in Healthy Adult Volunteers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Stem Cell Coated Fistula Plug in Patients With Crohn's RVF
Updated: 12/31/1969
A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Rectovaginal Fistulizing Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Stem Cell Coated Fistula Plug in Patients With Crohn's RVF
Updated: 12/31/1969
A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Rectovaginal Fistulizing Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
Updated: 12/31/1969
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
Status: Enrolling
Updated: 12/31/1969
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
Updated: 12/31/1969
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
Updated: 12/31/1969
The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases
Status: Enrolling
Updated: 12/31/1969
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
Updated: 12/31/1969
The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
Updated: 12/31/1969
Idelalisib (GS-1101)-Associated Colitis - Molecular and Cellular Mechanisms Research Proposal
Status: Enrolling
Updated: 12/31/1969
Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
Updated: 12/31/1969
Idelalisib (GS-1101)-Associated Colitis - Molecular and Cellular Mechanisms Research Proposal
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
Updated: 12/31/1969
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials